PLIANT THERAPEUTICS, INC. Operating Leases, Rent Expense
PLIANT THERAPEUTICS, INC. (PLRX) reported Operating Leases, Rent Expense of $2.50 million for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2022-03-01
- PLIANT THERAPEUTICS, INC. operating leases, rent expense for fiscal 2020 was $2.50M, a 0.00% change from fiscal 2019.
- PLIANT THERAPEUTICS, INC. operating leases, rent expense for fiscal 2019 was $2.50M.
| Period end | Operating Leases, Rent Expense 12 month |
|---|---|
| 2020-12-31 | $2.50M 10-K · filed 2022-03-01 |
| 2019-12-31 | $2.50M 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |